The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durability of responses with biweekly dosing of teclistamab in patients with relapsed/refractory multiple myeloma achieving a clinical response in the majesTEC-1 study.
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Lionel Karlin
Employment - Aguettant (I)
Honoraria - Abbvie; Abbvie; Amgen; Celgene; Janssen-Cilag; sanofi; sanofi; Takeda
Consulting or Advisory Role - Abbvie; Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Janssen-Cilag; Sanofi; Takeda
 
Lotfi Benboubker
Consulting or Advisory Role - Bretonneau Hospital, Regional University Hospital Center (Inst)
Travel, Accommodations, Expenses - Abbvie; Sanofi
Other Relationship - Bretonneau Hospital, Regional University Hospital Center (Inst)
 
Hareth Nahi
Employment - Genmab
Stock and Other Ownership Interests - Genmab
 
Jesús San-Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Haemalogix (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst); Sanofi (Inst); Secura Bio (Inst); Takeda (Inst)
 
Danielle Trancucci
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Keqin Qi
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Tara Stephenson
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Alfredo Perales-Puchalt
Employment - Geneos; Janssen
Stock and Other Ownership Interests - AstraZeneca; Geneos; GlaxoSmithKline; Globus; IgM Biosciences; Johnson & Johnson/Janssen; Merck; Pfizer; Vanda Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Methods and compositions for treating cancer - WO2016054153A1 Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR) - WO2018044929A1 (Inst)
 
Katherine Chastain
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda